Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AVNR

(AVNR) (AVNR) Stock Price, News & Analysis

(AVNR) logo

About (AVNR) Stock (NASDAQ:AVNR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare, is the only over-the-counter treatment for cold sores that has been approved by the United Sates Food and Drug Administration (FDA). In October 2010, FDA approved NUEDEXTA, is a combination of dextromethorphan/quinidine, for the treatment of pseudobulbar affect (PBA).

Receive AVNR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (AVNR) and its competitors with MarketBeat's FREE daily newsletter.

AVNR Stock News Headlines

5 Stocks Facing an Earnings Short Squeeze
They Won’t Tell You This About Gold
Inflation, digital currency, and government policy are quietly eating away at your savings — and most people won't realize it until it's too late. A new underground report, Gold’s Next Move, reveals why gold could be on the edge of a major breakout — and what you should be doing right now to protect your wealth before the next big move hits.
5 Biotech Options to Buy Right Now
See More Headlines

AVNR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that (AVNR) investors own include Tellurian (TELL), Meta Platforms (META), Avid Bioservices (CDMO), (GTATQ) (GTATQ), Netflix (NFLX), Nokia Oyj (NOK) and Alterity Therapeutics (PRAN).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:AVNR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:AVNR) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners